Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927028 · ClinicalTrials.gov registry record · NA
The Effects of Mastication on Energy Release From Walnuts
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02927028: Completed NA study, sponsored by Purdue University.
NCT02927028 is a NA study that has completed, run by Purdue University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927028, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
With an emphasis on oral processing, this study seeks to characterize the mechanisms that account for the high satiation properties of walnuts and low energy yield during digestion.
Primary Outcome
Released fat concentration following chewing.
Interventions
- OTHER Chewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2016-12-30 |
| Phase | NA |
What the finished NCT02927028 record still lists
NCT02927028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Chewing is the first listed.
NCT02927028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927028 about?
NCT02927028 is a clinical study titled "The Effects of Mastication on Energy Release From Walnuts". With an emphasis on oral processing, this study seeks to characterize the mechanisms that account for the high satiation properties of walnuts and low energy yield during digestion.
What is the current status of trial NCT02927028?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-08-01. Estimated completion is 2016-12-30.
What interventions are being tested in trial NCT02927028?
The interventions under investigation include: Chewing (OTHER).
Who is sponsoring clinical trial NCT02927028?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02927028's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI